semaglutide and bone loss GLP-1s loss! Does ozempic cause bone damage?

L., & Terry, D

Heres a look at common biologic classes and their half-lives: o Humira (adalimumab): 68 weeks o Enbrel (etanercept): 2 weeks o Remicade (infliximab): 46 weeks o Cosentyx (secukinumab): 4 weeks o Stelara (ustekinumab): 12 weeks o Tremfya (guselkumab): 8 weeks o Xeljanz (tofacitinib): 12 weeks o Rinvoq (upadacitinib): 12 weeks A common approach physicians might take to accommodate for the variation in drug half-lives is to stop one full dosing interval before major implant surgery for each biologic, with consideration for a longer hold where theres a high risk for infection or poor wound healing

It is essential to emphasise that these medications are not licensed for treating alcohol use disorder, and any such use would require careful clinical justification and informed patient consent

Such direct inhibitory action appears surprising for a peptide thought to be primarily involved in sleep promotion

NSAIDs have robust human RCT evidence for pain and inflammation but impair long-term tendon healing in some models

In addition to direct DNA damage, free radicals also influence carcinogenesis through the modulation of cellular signaling pathways